Diagnostic Value of F-18-FDG PET/CT in Patients with Carcinoma of Unknown Primary
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, vol.27, no.3, pp.126-132, 2018 (ESCI, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 27 Issue: 3
- Publication Date: 2018
- Doi Number: 10.4274/mirt.64426
- Journal Name: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
- Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.126-132
- Keywords: Fluorodeoxyglucose, positron emission tomography/computed tomography, metastasis, unknown primary neoplasms, POSITRON-EMISSION-TOMOGRAPHY, PRIMARY TUMORS, PRIMARY SITE, COMPUTED-TOMOGRAPHY, CLINICAL-VALUE, PRIMARY CUP, FDG-PET/CT, METASTASES, CANCER, F-18-FLUORODEOXYGLUCOSE
- Recep Tayyip Erdoğan University Affiliated: No
Abstract
Objective: The aim of this study is to investigate the clinical role of F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) in patients with carcinoma of unknown primary (CUP).